Biotech and medical business blog
Visit BioHealth Investor
JPMorgan Issues Coverage on Big Pharma Sector (BMY, LLY, PFE, WYE, MRK, SGP)
Posted on June 25, 2008
JPMorgan has come out with a relatively lackluster coverage in the Big Pharma sector, although not all calls are cautious.Bristol-Myers Squibb (NYSE: BMY), Eli Lilly & Co. (NYSE: LLY), Pfizer Inc. (NYSE: PFE), and Wyeth (NYSE: WYE) were all started in new coverage with Neutral ratings.Merck (NYSE: MRK) and Schering-Plough (NYSE: SGP) were started as [...]...
Original article linkTags:
pharma default explanation





Subscribe to BioHealth Investor